Free Trial

Marinus Pharmaceuticals (MRNS) Insider Trading & Ownership

Marinus Pharmaceuticals logo
$0.23 -0.01 (-3.56%)
(As of 12/20/2024 05:31 PM ET)

Marinus Pharmaceuticals (NASDAQ:MRNS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.46%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$27,432.79
Get MRNS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Marinus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MRNS Insider Buying and Selling by Quarter

Marinus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/5/2024Christina ShaferInsiderSell3,820$1.14$4,354.80  
8/5/2024Martha E ManningSVPSell3,621$1.13$4,091.73  
8/5/2024Scott BraunsteinCEOSell12,145$1.13$13,723.85  
8/5/2024Steven PfanstielCFOSell4,657$1.13$5,262.41  
(Data available from 1/1/2013 forward)

MRNS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Marinus Pharmaceuticals includes Christina Shafer, Martha E Manning, Scott Braunstein, Seth H Z Fischer, and Steven Pfanstiel. Learn more on insiders at MRNS.

5.46% of Marinus Pharmaceuticals stock is owned by insiders. Learn more on MRNS's insider holdings.

The following insiders have sold MRNS shares in the last 24 months: Christina Shafer ($27,060.00), Martha E Manning ($24,783.99), Scott Braunstein ($74,968.00), Seth H Z Fischer ($6,657.72), and Steven Pfanstiel ($31,879.01).

Insiders have sold a total of 39,018 Marinus Pharmaceuticals shares in the last 24 months for a total of $165,348.72 sold.

Marinus Pharmaceuticals Key Executives

  • Dr. Scott N. Braunstein M.D. (Age 61)
    CEO, President & Chairman
    Compensation: $1.01M
  • Dr. Alex Aimetti Ph.D.
    Chief Scientific Officer
  • Ms. Sonya Weigle
    Senior VP of Investor Relations, Human Resources & Corporate Affairs
  • Ms. Martha E. Manning Esq. (Age 69)
    J. D., Senior VP, General Counsel & Secretary
    1 recent trades
  • Molly Cameron
    Director of Corporate Communications & Investor Relations
  • Dr. Kimberly A. McCormick Pharm.D.
    Chief Regulatory & Quality Assurance Officer
  • Mr. Thomas J. Lyons
    Chief Business Officer
  • Mr. David Czekai
    Senior Vice President of Chemistry, Manufacturing & Controls
  • Dr. Mark Paternoster Ph.D.
    Senior Vice President of Development
  • Dr. Dayong Li Ph.D.
    Senior Vice President of Biometrics


This page (NASDAQ:MRNS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners